Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Naheed, Alam"'
Autor:
Nicole, Piscatelli, Nicole V, Hinchy, Jennifer, Frustino, Laura T, Reed, James, Zemer, Naheed, Alam, Paul, Hosking, Maureen A, Sullivan
Publikováno v:
General dentistry. 70(2)
This report presents a case in which oral soft tissue lesions were the first signs of multiple myeloma (MM) following a solid-organ transplantation. A 75-year-old man presented with bilateral primary oral gingival masses in the posterior mandible app
Autor:
John Loree, Mark Burke, Joseph Muscarella, Naheed Alam, Jenny Romero, Daniel Ford, Michael Nagai, Christopher Hughes, Saurin Rajnikant Popat, Thom R. Loree, Adam Szymanowiski
Publikováno v:
Journal of Clinical Oncology. 40:e18022-e18022
e18022 Background: Human Papilloma Virus (HPV) related tumors of the oropharynx have been associated with an increase in survival for patients. Induction chemotherapy followed by surgery can maintain survival in select oropharyngeal squamous cancers
Autor:
Doris Howell, Vikas Gupta, Jeffrey H. Lipton, J C Victor, Naheed Alam, David Loach, Samantha J Mayo, Kelly A. Metcalfe, Hans A. Messner, Dennis Dong Hwan Kim, Laura McGillis, Sean B. Rourke, Jieun Uhm, F V Michelis, C Piescic, John Kuruvilla, Anna Lambie, D Breen
Publikováno v:
Bone Marrow Transplantation. 51:841-847
Although neurocognitive impairment has been established as a major issue among cancer survivors, the real-world consequences of this impairment are unclear. This study investigated the relationship between neurocognitive functioning and medication ma
Autor:
Hans A. Messner, Jeffrey H. Lipton, Gupta, John Kuruvilla, Matthew Seftel, Jieun Uhm, Naheed Alam, Wei Xu, Dennis Dong Hwan Kim, Eshetu G. Atenafu
Publikováno v:
Bone Marrow Transplantation. 50:734-742
Steroid refractory acute GVHD (SR aGVHD) is associated with high morbidity and mortality. This study attempted to generate a risk model for SR aGVHD using 259 single nucleotide polymorphisms (SNPs) in 53 genes of recipients and donors. A total of 268
Autor:
Matthew Seftel, Ryan Del Bel, Wei Xu, Dennis Dong Hwan Kim, Naheed Alam, Jieun Uhm, Hans A. Messner, Nada Hamad, Jeffrey H. Lipton, John Kuruvilla, Vikas Gupta
Publikováno v:
Biology of Blood and Marrow Transplantation. 20(11):1722-1728
Graft-versus-host disease (GVHD) has no therapeutic benefit after hematopoietic cell transplantation (HCT) for patients with acquired aplastic anemia (AA), and its prevention is highly desirable. We designed a conditioning regimen using an intermedia
Autor:
John Kuruvilla, Jieun Uhm, Joon Ho Moon, Sang Kyun Sohn, Vikas Gupta, Jeffrey H. Lipton, Matthew D. Seftel, Nada Hamad, Naheed Alam, Hans A. Messner, Dennis Dong Hwan Kim
Publikováno v:
Annals of hematology. 96(5)
The CIBMTR chronic graft-versus-host disease (cGVHD) risk score can be refined and improved for better prognostic stratification. Three hundred and seven consecutive patients diagnosed with cGVHD by the NIH consensus criteria were retrospectively rev
Autor:
Arkadiusz Z. Dudek, Alexander M. Truskinovsky, Maureen F. Zakowski, Atul Kapoor, Naheed Alam, Marc Ladanyi, Karen S. Gustafson
Publikováno v:
Clinical Lung Cancer. 11:E1-E4
Activating mutations in the epidermal growth factor receptor (EGFR) gene are extremely rare in small-cell lung cancer (SCLC). Here, we present a case of an EGFR-mutant gefitinib-responsive non-small-cell lung cancer (NSCLC) of adenocarcinoma histolog
Autor:
Hans A. Messner, Eshetu G. Atenafu, D.H. Kim, John Kuruvilla, Vikas Gupta, Jeffrey H. Lipton, Naheed Alam, Jieun Uhm, Matthew Seftel
Publikováno v:
Bone marrow transplantation. 50(9)
We studied outcomes of 65 consecutive patients with therapy-related AML/myelodyplastic syndrome (t-AML/MDS) who underwent allogeneic hematopoietic cell transplantation (HCT). Previously published scores of HCT-CI, CIBMTR, EBMT and Comorbidity-age ind
Autor:
F V Michelis, Eshetu G. Atenafu, Matthew D. Seftel, Naheed Alam, Jeffrey H. Lipton, Jieun Uhm, John Kuruvilla, Hans A. Messner, Anna Lambie, Laura McGillis, Vikas Gupta, Dennis Dong Hwan Kim, David Loach
Publikováno v:
Bone marrow transplantation. 50(7)
Secondary AML (sAML) has a poor prognosis with conventional chemotherapy alone. Allogeneic hematopoietic cell transplantation (HCT) is beneficial for high-risk AML. Data comparing outcomes of transplants for patients with de novo and sAML are limited
Autor:
Vikas Gupta, John Kuruvilla, Jieun Uhm, Dennis Dong Hwan Kim, Anna Lambie, Matthew D. Seftel, Fotios V. Michelis, Naheed Alam, Jeffrey H. Lipton, Hans A. Messner, Laura McGillis
Publikováno v:
Clinical lymphoma, myelomaleukemia. 15(5)
Introduction Risk scores have been developed for allogeneic hematopoietic cell transplantation (HCT) outcomes, such as the Hematopoietic Cell Transplantation-Comorbidity Index (HCT-CI) and the modified European Group for Blood and Marrow Transplantat